Found: 10
Select item for more details and to access through your institution.
Correction to: Real-World Recurrence Rates and Economic Burden in Patients with Resected Early-Stage Melanoma.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Real-World Recurrence Rates and Economic Burden in Patients with Resected Early-Stage Melanoma.
- Published in:
- Dermatology & Therapy, 2020, v. 10, n. 5, p. 985, doi. 10.1007/s13555-020-00404-9
- By:
- Publication type:
- Article
Effect of a patient decision aid (PDA) for type 2 diabetes on knowledge, decisional self-efficacy, and decisional conflict.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A Cross-Sectional Real-World Evaluation of the Health-Related Quality of Life Burden in Patients with Chronic Lymphocytic Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S279, doi. 10.1016/j.clml.2019.07.215
- By:
- Publication type:
- Article
Changing Patients' Treatment Preferences and Values with a Decision Aid for Type 2 Diabetes Mellitus: Results from the Treatment Arm of a Randomized Controlled Trial.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 2, p. 803, doi. 10.1007/s13300-018-0391-7
- By:
- Publication type:
- Article
Health-related quality of life and treatment satisfaction in Chronic Lymphocytic Leukemia (CLL) patients on ibrutinib compared to other CLL treatments in a real-world US cross sectional study.
- Published in:
- PLoS ONE, 2022, v. 17, n. 10, p. 1, doi. 10.1371/journal.pone.0270291
- By:
- Publication type:
- Article
Bleeding-associated outcomes with preoperative clopidogrel use in on- and off-pump coronary artery bypass.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2012, v. 34, n. 1, p. 56, doi. 10.1007/s11239-012-0694-x
- By:
- Publication type:
- Article
Health-related quality of life (QoL) in patients with advanced melanoma receiving immunotherapies in real-world clinical practice settings.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Real-world Clinical Outcomes of First-Line Ibrutinib or Chemoimmunotherapy in Patients with Chronic Lymphocytic Leukemia by Risk Status.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 7, p. 3292, doi. 10.1007/s12325-021-01991-5
- By:
- Publication type:
- Article
Consensus and Discordance in the Management of Growth Hormone-Treated Patients: Results of a Knowledge, Attitudes, Beliefs, and Practices Survey.
- Published in:
- International Journal of Pediatric Endocrinology, 2010, p. 1, doi. 10.1155/2010/891571
- By:
- Publication type:
- Article